[#DIV28SUPER] Notice of NIH Blueprint MedTech program

New NIH MedTech program aims to accelerate medical devices to treat, diagnose nervous system disorders   Incubator hubs will provide subawards to technology innovation teams The National Institutes of Health, through its Blueprint MedTech program, has established two incubator hubs and launched a funding solicitation in support of commercially viable, clinically focused neurotechnology solutions to diagnose and treat disorders of the nervous system. Blueprint MedTech relies on the collaborative framework of the NIH Blueprint for Neuroscience Research, which includes the NIH Office of the Director and 12 NIH institutes and centers that support research on the nervous system. Two incubator hubs for the program—the Center for Innovative NeuroTech Advancement (CINTA) and NeuroTech Harbor (NTH)—competed successfully to become technology accelerators for the program. CINTA is a component of the Consortia for Improving Medicine with Innovation and Technology (CIMIT), a network of academic and medical institutions, based in Boston. NTH is a collaboration among scientists, engineers, and clinicians from Johns Hopkins University, Baltimore, and Howard University, Washington, D.C. CINTA and NTH have launched a funding opportunity on behalf of the NIH program. This program will catalyze the translation of novel neurotechnologies from early-stage development to first-in-human clinical studies.  Read the full funding announcement here. For more information, read the NIBIB Science Highlight.